These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 23845468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
    Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB.
    J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
    [Abstract] [Full Text] [Related]

  • 3. The complementary role of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in diagnosis of Hodgkin's lymphoma.
    Masoud R, Ibrahiem A, Tantawy D, Eldosoky I.
    Ann Diagn Pathol; 2019 Oct; 42():64-68. PubMed ID: 31319330
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A, Gloghini A, Volpe R.
    Cancer; 1992 Dec 01; 70(11):2691-8. PubMed ID: 1330287
    [Abstract] [Full Text] [Related]

  • 5. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
    Cozzolino I, Vitagliano G, Caputo A, Montella M, Franco R, Ciancia G, Selleri C, Zeppa P.
    Diagn Cytopathol; 2020 Mar 01; 48(3):211-216. PubMed ID: 31825183
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J, Herrmann F.
    Leuk Lymphoma; 1996 Feb 01; 20(5-6):397-409. PubMed ID: 8833395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
    Gomez-Gelvez JC, Smith LB.
    Arch Pathol Lab Med; 2015 Oct 01; 139(10):1205-10. PubMed ID: 26414463
    [Abstract] [Full Text] [Related]

  • 14. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.
    Am J Surg Pathol; 2008 Feb 01; 32(2):304-15. PubMed ID: 18223334
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Study on the origin of H/RS cell and their biological behavior in Hodgkin lymphoma by using multiple mark techniques].
    Wang JF, Xi YF, Wang LX, Yin WD, Zhang JW, Gong FC.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct 01; 25(10):579-82. PubMed ID: 15634588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma.
    Hartmann S, Goncharova O, Portyanko A, Sabattini E, Meinel J, Küppers R, Agostinelli C, Pileri SA, Hansmann ML.
    Mod Pathol; 2019 Jan 01; 32(1):37-47. PubMed ID: 30140037
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.